慢性戊型肝炎临床管理的最新研究进展

摘要/Abstract

摘要： 既往认为戊型肝炎病毒(HEV)感染仅能引起急性肝炎,自2008年在移植患者中发现慢性戊型肝炎,改变了我们对这个病毒的认识,特定基因型的HEV可以在免疫缺陷人群中导致慢性感染。近年来,慢性HEV感染流行病学、传播途径、病理生理机制、临床特点和诊治领域得到了更多的完善和补充。然而仍存在很多挑战,尤其是疾病预防和提高临床预后方面。本文旨在更新慢性戊肝患者的临床管理策略并讨论未来科学研究方向及有效治疗方案。

关键词: 戊型肝炎病毒, 慢性戊型肝炎, 免疫缺陷, 流行病学

钱聪, 谢青. 慢性戊型肝炎临床管理的最新研究进展[J]. 肝脏, 2023, 28(5): 599-603.

参考文献

[1] World Health Organization. Hepatitis E, https://www.who.int/zh/news-room/fact-sheets/detail/hepatitis-e
[2] Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med, 2008,358(8):811-817.
[3] Dalton HR, Bendall RP, Keane FE, et al. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med, 2009,361(10):1025-1027.
[4] Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology, 2011,140(5):1481-1489.
[5] Buescher G, Ozga AK, Lorenz E, et al. Hepatitis E seroprevalence and viremia rate in immunocompromised patients: a systematic review and meta-analysis. Liver Int, 2021, 41(3):449-455.
[6] Koning L, Charlton MR, Pas SD, et al. Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States. BMC Infect Dis, 2015,15:371.
[7] Lampejo T, Curtis C, Ijaz S, et al. Nosocomial transmission of hepatitis E virus and development of chronic infection: The wider impact of COVID-19. J Clin Virol, 2022,148:105083.
[8] Geng Y, Zhang H, Huang W, et al. Persistent hepatitis e virus genotype 4 infection in a child with acute lymphoblastic leukemia. Hepat Mon, 2014,14(1):e15618.
[9] Abravanel F, Lhomme S, El Costa H, et al. Rabbit Hepatitis E Virus Infections in Humans, France. Emerg Infect Dis, 2017,23(7):1191-1193.
[10] Sahli R, Fraga M, Semela D, et al. Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland. J Hepatol, 2019,70(5):1023-1025.
[11] Sridhar S, Yip CC, Wu S, et al. Transmission of Rat Hepatitis E Virus Infection to Humans in Hong Kong: A Clinical and Epidemiological Analysis. Hepatology, 2021, 73(1):10-22.
[12] Costafreda MI, Sauleda S, Rico A, et al. Detection of non-enveloped hepatitis E virus in plasma of infected blood donors. J Infect Dis, 2021 4:jiab589.
[13] Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion, 2004,44(6):934-940.
[14] Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet, 2014,384(9956):1766-1773.
[15] Mansuy JM, Gallian P, Dimeglio C, et al. A nationwide survey of hepatitis E viral infection in French blood donors. Hepatology, 2016, 63(4):1145-1154.
[16] Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet, 2010,376(9744):895-902.
[17] Zaman K, Dudman S, Stene-Johansen K, et al. HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh. BMJ Open, 2020,10(1):e033702.
[18] Borentain P, Colson P, Bolon E, et al. Hepatocellular carcinoma complicating hepatitis E virus-related cirrhosis. Hepatology, 2018,67(1):446-448.
[19] Zhou X, Huang F, Xu L, et al. Hepatitis E Virus Infects Neurons and Brains. J Infect Dis, 2017,215(8):1197-1206.
[20] Tian J, Shi R, Liu T, et al. Brain Infection by Hepatitis E Virus Probably via Damage of the Blood-Brain Barrier Due to Alterations of Tight Junction Proteins. Front Cell Infect Microbiol, 2019,9:52.
[21] Horvatits T, Wi?mann JE, Johne R, et al. Hepatitis E virus persists in the ejaculate of chronically infected men. J Hepatol, 2021,75(1):55-63.
[22] Bremer W, Blasczyk H, Yin X, et al. Resolution of hepatitis E virus infection in CD8+ T cell-depleted rhesus macaques. J Hepatol, 2021,75(3):557-564.
[23] Senosiain C, González-Tallón A A, López-Sanromán A, et al. Hepatitis E seroprevalence in inflammatory bowel disease. Gastroenterol Hepatol, 2016,39(3):185-190.
[24] Pischke S, Stiefel P, Franz B, et al. Chronic hepatitis e in heart transplant recipients. Am J Transplant,2012,12(11):3128-3133.
[25] Cornberg M, Pischke S, Müller T, et al. Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E - The HepNet SofE pilot study. J Hepatol, 2020,73(3):696-699.
[26] Li Y, Yu P, Kessler AL, et al. Hepatitis E virus infection activates NOD-like receptor family pyrin domain-containing 3 inflammasome antagonizing interferon response but therapeutically targetable. Hepatology, 2022,75(1):196-212.
[27] European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol, 2018,68(6):1256-1271.
[28] Kamar N, Abravanel F, Behrendt P, et al. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study. Clin Infect Dis, 2020,71(5):1204-1211.
[29] Kamar N, Izopet J, Tripon S, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med, 2014,370(12):1111-1120.
[30] Kamar N, Chatelut E, Manolis E, et al. Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function. Am J Kidney Dis, 2004,43(1):140-146.
[31] Todt D, Gisa A, Radonic A, et al. In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome. Gut, 2016,65(10):1733-1743.
[32] Kamar N, Rostaing L, Abravanel F, et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis, 2010,50(5):e30-33.
[33] Sridhar S, Chan JFW, Yap DYH, et al. Genotype 4 hepatitis E virus is a cause of chronic hepatitis in renal transplant recipients in Hong Kong. J Viral Hepat, 2018 Feb,25(2):209-213.